| Patent Number |
Title Of Patent |
Date Issued |
| 7229622 |
Synthetic chimeric fimbrin peptides |
June 12, 2007 |
| The present invention provides synthetic chimeric fimbrin peptides which induce an immunogenic response in animals to non-typable Haemophilus influenzae and that do not require tedious purification techniques. The synthetic chimeric fimbrin peptides reduce the severity of otitis media |
| 7220822 |
CD28 mimetics for blocking T cell mediated immune reactions |
May 22, 2007 |
| Agents for blocking T cell-mediated immune reactions are provided. Such agents are peptides, referred to as "CD28 peptide mimetics", of from 15 to 30 amino acids in length. The CD28 peptide mimetics comprise the hexapeptide motif `MYPPPY`, SEQ ID NO: 1, or a retro-inverso isomer ther |
| 7060284 |
Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
June 13, 2006 |
| Compositions for stimulating the immune system and for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include immunogenic epitopes of the HER-2 proteins and chimeric and multivalent peptides which comprise such epitopes. The |
| 6436405 |
Synthetic chimeric fimbrin peptides |
August 20, 2002 |
| The present invention provides synthetic chimeric fimbrin peptides which induce an immunogenic response in animals to non-typable Haemophilus influenzae and that do not require tedious purification techniques. The synthetic chimeric fimbrin peptides reduce the severity of otitis media |
| 5843464 |
Synthetic chimeric fimbrin peptides |
December 1, 1998 |
| The present invention provides synthetic chimeric fimbrin peptides which induce an immunogenic response in animals to non-typable Haemophilus influenzae and that do not require tedious purification techniques. The synthetic chimeric fimbrin peptides reduce the severity of otitis media |
